Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly presents data from post-hoc analyses of linagliptin
Eli Lilly presents data from post-hoc analyses of linagliptin
Eli Lilly presents data from post-hoc analyses of linagliptin
Submitted by
admin
on September 24, 2013 - 10:09am
Source:
Yahoo/Fly on the Wall
News Tags:
Eli Lilly
linagliptin
Boehringer Ingelheim
diabetes
Headline:
Eli Lilly presents data from post-hoc analyses of linagliptin
Do Not Allow Advertisers to Use My Personal information
